Vestal Point Capital »

Ascendis Pharma A S shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $102M 750k 136.38

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
Artisan Partners Limited Partnership
Henderson Group
Franklin Resources
T. Rowe Price Associates
Massachusetts Financial Services
Invesco
Vestal Point Capital
Sofinnova Ventures
Paradigm Biocapital Advisors
TimesSquare Capital Management
Citadel Advisors
Brown Advisory Holdings Incorporated
Alliancebernstein

View all funds holding Ascendis Pharma A S